Parosmia: Pathophysiology and Management
- PMID: 39821581
- DOI: 10.1007/s11882-024-01189-z
Parosmia: Pathophysiology and Management
Abstract
Purpose of review: Parosmia is a qualitative olfactory disorder in which there is a mismatch between the memory of an odor and the actual experience triggered by an odor. There has been a surge in parosmia-related publications since the COVID-19 pandemic. This review summarizes the latest clinical findings, theories on pathophysiology and potential treatment options.
Recent advances: Potential models of parosmia include peripheral or central hypotheses, which refer to aberrancies in olfactory neuron regeneration or information processing in central olfactory centers respectively. This leads to an incomplete or disorganized pattern of olfactory information relay. Studies using gas chromatography and functional magnetic resonance imaging have identified molecular triggers and intracranial functional connectivity patterns in parosmia respectively. Parosmia tends to occur in a delayed fashion after virus-induced anosmia. It may run a protracted course, but typically improves over time. Currently there are no generally approved, objective ways to ascertain the presence and measure the extent of parosmia. Evidence-based treatment for parosmia remains elusive. In some people, this can lead to health and quality of life issues.
Keywords: COVID-19; Dysosmia; Olfactory loss; Olfactory training; Parosmia; Qualitative olfactory dysfunction.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. No funds, grants, or other support was received for this study. Since 2021, Thomas Hummel collaborates with the following companies: Sony, Tokyo, Japan; Smell and Taste Lab Geneva, Switzerland; Takasago, Paris, France; Cyrano, Delray Beach, FL, USA; Cynexo, Trieste, Italy; Sentosphere, Paris, France; NOAR, Sao Paulo, Brazil; Baia Foods, Madrid, Spain; Burghart, Holm, Germany. The remaining authors have no conflicts of interest to declare. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors. Competing Interests: The authors declare no competing interests.
References
-
- Hernandez AK, Landis BN, Altundag A, Fjaeldstad AW, Gane S, Holbrook EH, Huart C, Konstantinidis I, Lechner M, Macchi A, et al. Olfactory nomenclature: an orchestrated effort to clarify terms and definitions of Dysosmia, anosmia, Hyposmia, Normosmia, Hyperosmia, olfactory intolerance, Parosmia, and Phantosmia/olfactory hallucination. ORL J Otorhinolaryngol Relat Spec. 2023;85(6):312–20. https://doi.org/10.1159/000530211 . - DOI - PubMed
-
- Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114(10):1764–9. https://doi.org/10.1097/00005537-200410000-00017 . - DOI - PubMed
-
- Nordin S, Bramerson A, Millqvist E, Bende M. Prevalence of parosmia: the Skovde population-based studies. Rhinology. 2007;45(1):50–3. - PubMed
-
- Olofsson JK, Ekesten F, Nordin S. Olfactory distortions in the general population. Sci Rep. 2022;12(1):9776. https://doi.org/10.1038/s41598-022-13201-5 . - DOI - PubMed - PMC
-
- Nordin S, Murphy C, Davidson TM, Quinonez C, Jalowayski AA, Ellison DW. Prevalence and assessment of qualitative olfactory dysfunction in different age groups. Laryngoscope. 1996;106(6):739–44. https://doi.org/10.1097/00005537-199606000-00014 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials